FTIR biochemical imaging of the prostate: An in-vitro proof of concept study

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 6628, Issue , 2007, Pages

  Aning, J J ^a   Isabelle, M ^a   Uff, J ^a   Ritchie, A W S ^a   Gilbert, H W ^a   Stone, N ^a  

^a GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

Author keywords

Biochemical fitting; FTIR; Non negative least squares; Prostate; Prostate cancer; Prostatic intraepithelial neoplasia; Spectroscopy

Indexed keywords

BIOCHEMICAL FITTING TECHNIQUE; GOLD STANDARD HISTOPATHOLOGY; LINEAR DISCRIMINANT ANALYSIS; PROSTATE TISSUE;

DATA STRUCTURES; DATABASE SYSTEMS; FOURIER TRANSFORM INFRARED SPECTROSCOPY; MEDICAL IMAGING; ONCOLOGY; PRINCIPAL COMPONENT ANALYSIS;

BIOCHEMICAL ENGINEERING;

EID: 36249006019     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: None     Document Type: Conference Paper

References (17)

1. Ferlay, J, Autier P, Boniol M, Heanue M, Colombet, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 18(3) 581-592, 2007.
2. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2006. CA Cancer J Clin. 56:106-30, 2006.
3. Johansson JE, Andren O, Andersson SO, et al. Natural history of early, localised prostate cancer. JAMA. 291: 2713-9, 2004.
4. Klotz L. Active surveillance for prostate cancer: for whom? J Clin Oncol. 23:8165-9, 2005.
5. McGregor M, Hanley JA, Boivin JF, Mclean RG. Screening for prostate cancer: estimating the magnitude of over-detection. CMAJ. 159:1368-72, 1998.
6. Gleason DF, Mellinger GT. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol, 11:58-64, 1974.
7. Lattouf JB, Saad F. Gleason score on biopsy: is it reliable for predicting the final grade on pathology? BJU Int. 90:694-699, 2002.
8. German MJ, Hammiche A, Ragavan N, Tobin MJ, Cooper LJ, Matanhelia SS, Hindley A, Nicholson CM, Fullwood NJ, Pollock HM, Martin FL. Infrared spectroscopy with multivariate analysis potentially facilitates the segregation of different types of prostate cell. Biophys J. 90:3783-3795, 2006.
9. Paluszkiewicz C, Kwiatek WM, Banas A, Kisiel A, Marcelli A, Piccinini M. ST-FTIR spectroscopic preliminary findings of non-cancerous, cancerous and hyperplastic human prostate tissues. Vib Spectrosc. 43:237-242, 2007.
10. Fernandez DC, Bhargava R, Hewitt SM, Levin IW. Infrared spectroscopic imaging for histopathologic recognition. 23(4): 469-474, 2005.
11. Malins DC, Polissar NL, Gunselman SJ. Models of DNA structure achieve almost perfect discrimination between normal prostate, benign prostatic hyperplasia (BPH), and adenocarcinoma and have a high potential for predicting BPH and prostate cancer. Proc. Natl. Acad. Sci USA. 94:259-264, 1997.
12. Gazi E, Dwyer J, Lockyer P, Miyan J, Gardiner P, Hart C, Brown M, Clarke NW. Applications of Fourier transform infrared microspectroscopy in studies of benign prostate and prostate cancer. A pilot study. J Pathol. 201:99-108, 2003.
13. Allam CK, Bostwick DG, Hayes JA, Upton MP, Wade CG, Domanowski GF, Klein MA, Boling EA, Stilmant MM. Interobserver variability in the diagnosis of high grade prostatic intraepithelial neoplasia and adenocarcinoma. Mod Pathol. 9(7): 742-751, 1996
14. Bostwick DG. High grade intraepithelial neoplasia. The most likely precursor of prostate cancer. Cancer 75:1823-1836, 1995
15. Sowa, Michael G, Smith, Michael S.D, Kendall, Catherine, Bock, Erika R, Ko, Alex C.T, Choo-Smith, Lin-P'ing, Stone, Nicholas. Semi-Parametric Estimation in the Compositional Modeling of Multicomponent Systems from Raman Spectroscopic Data. Applied Spectroscopy. 60(8): 877-883, 2006
16. Mahadevan-Jansen A, Richards-Kortum RR. Raman spectroscopy for the detection of cancers and precancers. Journal of Biomedical Optics. 1( 1):31-70, 1996
17. Sharma U, Mehta A, Seenu V, Jagannathan NR. Biochemical characterization of metastatic lymph nodes of breast cancer patients by in vitro 1H magnetic resonance spectroscopy: a pilot study. Mag Res lmag. 22:697-706, 2004